The "Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Tablets, Capsules, Powders, Granules), Mechanism (Controlled Release, Immediate Release), End-use, and Region with Growth Forecasts, 2025-2030" has been added to ResearchAndMarkets.com's offering.

The Oral Solid Dosage Contract Manufacturing Market is poised for significant growth, projected to expand from USD 38.64 billion in 2024 to USD 54.72 billion by 2030, at a CAGR of 5.99%. This surge is driven by the increasing complexity of new drug molecules, strategic investments by CMOs and CDMOs in R&D, and the rising demand for novel therapies.

Oral solids continue to dominate the pharmaceutical sector due to their cost-effectiveness, straightforward manufacturing, and patient compliance. Innovations in drug delivery, including controlled and sustained release formations, are enhancing the bioavailability of oral solids and reducing the frequency of drug administration, further unlocking market potential.

The nutraceutical and pharmaceutical industries are actively advancing the development of oral solid dosage forms (OSD). The consumer preference for these dosage forms is attributed to their user-friendly nature and patient adherence. Future technological advancements in the bulk manufacturing of OSD forms are anticipated to significantly drive demand.

CMOs and CDMOs are pivotal in enhancing manufacturing processes, with R&D investments contributing to groundbreaking innovations in formulation development and analytical technologies. This progress enables more efficient and advanced manufacturing techniques, expanding production capabilities, thereby meeting the rising demand from pharmaceutical companies.

Strategic movements in 2023 include significant collaborations and investments:

• In July 2023, Aenova Group partnered with Galvita to enhance oral dosage formulation, production, and development.
• Aenova invested about USD 21.96 million in April 2023 to expand its Tittmoning high-volume solids site, boosting capacity.
• In January 2023, Catalent and Ethicann collaborated to develop Ethicann's clinical drug pipeline using Catalent's ODT technology.

Oral Solid Dosage Contract Manufacturing Market Report Highlights:

• Tablets led the market with a 32.74% revenue share in 2024. Their efficacy, ease of manufacturing, and self-administration convenience are significant market drivers. Growing demand for bilayer tablets and investments in formulation technologies are set to propel this segment.
• The controlled release segment also dominated, due to innovations in controlled release systems like dual drug tablets and polymer nanosystems, ensuring targeted drug delivery and boosting growth.
• The large-size companies segment held the largest share in 2024, as more pharma companies are outsourcing to large CMOs, enhancing adaptability and collaboration across the industry.
• Asia-Pacific led globally in 2024, forecasted to continue rapid growth due to competitive pricing in China and India, and expanding pharmaceutical manufacturing facilities in Singapore and South Korea.

This report addresses:

• Market intelligence for effective decisions
• Revenue forecasts from 2018 to 2030
• Growth opportunities and trends
• Regional and segment revenue assessments
• Competitive strategy and market share analysis
• Listings of product innovations

Why Should You Buy This Report?

• Comprehensive Market Analysis: Gain detailed insights into the market across key regions and segments.
• Competitive Landscape: Assess the presence of major players.
• Future Trends: Understand the drivers shaping the market's future.
• Actionable Recommendations: Identify new revenue streams and guide strategic business decisions.

Companies Profiled Include:

• Catalent Inc.
• Lonza
• Aenova Group
• Boehringer Ingelheim International GmbH
• Jubilant Pharmova Limited
• Patheon Pharma Services
• Recipharm AB.
• Corden Pharma International
• Siegfried Holding AG
• Piramal Pharma Solutions
• AbbVie Contract Manufacturing
• Next Pharma AB

Key Attributes:

Key Topics Covered:

• Chapter 1. Methodology and Scope
  • Market Segmentation & Scope
  • Market Definitions
  • Research Methodology
  • Information or Data Analysis
  • Model Details
  • List of Secondary Sources
  • List of Abbreviations
  • Objectives
• Chapter 2. Executive Summary
  • Market Outlook
  • Segment Snapshot
  • Competitive Landscape Snapshot
• Chapter 3. Market Variables, Trends, & Scope
  • Market Lineage Outlook
  • Market Trends and Outlook
  • Market Dynamics
  • Technology Landscape
  • Pricing Model Analysis
  • Industry Analysis Tools
• Chapter 4. Oral Solid Dosage Contract Manufacturing Market: Product Estimates & Trend Analysis
  
  
  • Oral Solid Dosage Contract Manufacturing Market; Product Movement Analysis
  • Oral Solid Dosage Contract Manufacturing Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • Tablets
  • Capsules
  • Powders
  • Granules
  • Others
• Chapter 5. Oral Solid Dosage Contract Manufacturing Market: Mechanism Estimates & Trend Analysis
  
  
  • Oral Solid Dosage Contract Manufacturing Market; Mechanism Movement Analysis
  • Oral Solid Dosage Contract Manufacturing Size & Trend Analysis, by Mechanism, 2018 to 2030 (USD Million)
  • Immediate Release
  • Delayed Release
  • Controlled Release
• Chapter 6. Oral Solid Dosage Contract Manufacturing Market: End Use Estimates & Trend Analysis
  • Oral Solid Dosage Contract Manufacturing Market; End Use Movement Analysis
  • Oral Solid Dosage Contract Manufacturing Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • Large Size Companies
  • Medium & Small Size Companies
  • Others
• Chapter 7. Oral Solid Dosage Contract Manufacturing Market: Regional Business Analysis
  • Regional Dashboard
  • Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA
• Chapter 8. Competitive Landscape
  • Company Categorization
  • Company Market Position Analysis, 2024
  • Company Profiles
    • Catalent Inc.
    • Lonza
    • Aenova Group
    • Boehringer Ingelheim International GmbH
    • Jubilant Pharmova Limited
    • Patheon Pharma Services
    • Recipharm AB.
    • Corden Pharma International
    • Siegfried Holding AG
    • Piramal Pharma Solutions
    • AbbVie Contract Manufacturing
    • Next Pharma AB

For more information about this report visit https://www.researchandmarkets.com/r/ifqofk

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250801864062/en/